In addition, a clinical study enrolled 201 patients undergoing liver biopsy for suspected NAFLD, examined the relation of PCSK9 with liver damage and showed that circulating concentration of PCSK9 was significantly related to liver steatosis grade (P = 0.012) [13]. The gene discussed is PCSK9; the disease is metabolic dysfunction-associated steatotic liver disease.